Beyond the Horizon: Psychedelics and the Future of Mental Health Care

November 11, 2025

Psychedelics such as psilocybin, LSD, MDMA, and ketamine are emerging as promising treatments for depression, PTSD, and substance use disorders. Recent clinical trials and neurobiological studies have highlighted their unique mechanisms, which have opened up a new realm in possible psychiatric treatments. This session will provide attendees with an evidence-based overview of therapeutic potential, safety considerations, and future directions in psychedelic treatments and psychedelic-assisted therapy.

Target Audience

  • Physicians
  • Physician Assistants
  • Advanced Practice Nurses
  • Registered Nurses
  • Licensed Practical Nurses

Learning Objectives

Learners will be able to:

  • Describe the historical context, regulatory changes, and cultural factors that have influenced the use of psychedelics in psychiatry.
  • Summarize current evidence from clinical trials regarding the efficacy and safety of psychedelics in treating psychiatric disorders such as depression, PTSD, and substance use disorders.
  • Differentiate between major classes of psychedelic compounds (e.g., classic serotonergic psychedelics, ketamine, and MDMA) and explain their proposed mechanisms of action.
  • Identify ethical, legal, and clinical considerations in the potential integration of psychedelic-assisted therapies into psychiatric practice.

You may also be interested in

Stroke Program Management Basic Training

This workshop is designed to equip nurses and healthcare professionals transitioning into the stroke coordinator role with the essential knowledge, skills, and tools to lead successful stroke programs.
Parkinson Disease: Diagnosis and Management

Participants will learn how to effectively manage Parkinson Disease (PD) by reviewing current diagnostic tools and treatment options. The session will cover the basic pharmacology and treatment of PD, with a particular emphasis on newer therapeutic approaches, including infusion therapies.
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™

    TeleSpecialists is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    TeleSpecialists designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Course opens: 
09/02/2025
Course expires: 
11/10/2026
Event starts: 
11/11/2025 - 2:00pm EST
Event ends: 
11/11/2025 - 3:00pm EST
Add to calendar: 
Rating: 
0
Speaker(s)

Sunny Shah, DO

has no relevant financial relationships to disclose at this time.
Moderator(s)

Debra Chionis, MS, ACE-MES, ACSM-CEP

has no relevant financial relationships to disclose at this time.
Peer Reviewer(s)

Lorianne Avino, D.O

has no relevant financial relationships to disclose at this time.
Planner(s)

Caitlyn Boyd, MHA, MSN, RN, CPHQ, CPAHA-Telestroke

has no relevant financial relationships to disclose at this time.

Muhammad Saeed, Bcom

has no relevant financial relationships to disclose at this time.

This activity has been submitted to Emergency Nurses Association for approval to award contact hours. Emergency Nurses Association is accredited as an approver of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™

    TeleSpecialists is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    TeleSpecialists designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Please login or register to take this course.